Achieving Sustained HIV Epidemic Control through Comprehensive HIV/AIDS Prevention, Care and Treatment Services in Major Public Hospitals, and a Mix of Public and Private Health Facilities in Nine Departments of Haiti under PEPFAR | CDC RFA GH20 2031

Opportunity Information: Apply for CDC RFA GH20 2031

This funding opportunity, titled "Achieving Sustained HIV Epidemic Control through Comprehensive HIV/AIDS Prevention, Care and Treatment Services in Major Public Hospitals, and a Mix of Public and Private Health Facilities in Nine Departments of Haiti under PEPFAR," is a CDC cooperative agreement designed to help Haiti sustain control of its HIV epidemic by strengthening HIV and TB clinical services across the Ministry of Public Health and Population (MSPP) facility network. The overarching goal is to accelerate progress toward the UNAIDS 95-95-95 targets, meaning more people with HIV are diagnosed, more diagnosed people start and stay on antiretroviral therapy (ART), and more people on ART achieve viral suppression. The opportunity is positioned as a direct contribution to the priorities of PEPFAR Haiti as well as Haiti's national HIV/AIDS program (PNLS) and MSPP, with an emphasis on closing persistent service gaps that affect both HIV outcomes and broader public health.

The CDC lists this as a discretionary award using a cooperative agreement mechanism, which typically means the recipient would implement program activities with substantial technical involvement from CDC, rather than operating fully independently. The opportunity number is CDC RFA GH20-2031, under CFDA 93.067 (health). It was originally posted January 15, 2020 with an application deadline of March 15, 2020 (11:59 p.m. ET for electronic submissions). The CDC anticipated one award. Although the narrative notes an "Award Ceiling for Year 1 is 0 (none)," the same notice also states CDC anticipated approximately $10,000,000 in total fiscal year funding for Year 1, explicitly subject to availability of funds. In practice, that combination usually signals that final award amounts and ceilings would be determined later (or structured across budget categories) even though an estimated funding level is provided for planning.

Programmatically, the NOFO is built around a set of linked strategies meant to improve HIV case detection, speed up treatment initiation, and keep patients engaged in high-quality services long enough to achieve durable viral suppression. First, it calls for optimizing HIV case-finding by shifting toward higher-yield HIV testing and counseling strategies and reducing broad generalized testing that finds fewer new cases per test. This reflects a targeted approach that prioritizes smarter testing modalities, better identification of people at higher risk, and more efficient use of limited testing resources while still ensuring access for those who need it.

Second, the NOFO emphasizes a structured package of services for people newly identified as living with HIV to strengthen immediate linkage to care and promote early ART initiation. The intent is to reduce drop-off between diagnosis and treatment start, a common point where programs lose patients. The focus on linkage suggests activities such as rapid referral, patient navigation, follow-up, and practical supports that help people overcome logistical and social barriers to starting treatment quickly.

Third, the opportunity centers on delivering high-quality, stigma-free, client-centered HIV and TB prevention, care, and treatment services, including prevention of mother-to-child transmission (PMTCT). The wording highlights retention as a critical outcome: keeping people living with HIV on ART over time, not just starting them on medication. It explicitly calls attention to populations that often face the greatest barriers to consistent care and the highest vulnerability to poor outcomes, including key populations, orphans and vulnerable children, and adolescent girls and young women. The inclusion of TB alongside HIV reflects the clinical reality that TB remains a major cause of illness and death among people with HIV, making integrated HIV/TB services essential for reducing morbidity and mortality.

Fourth, the NOFO prioritizes strengthening monitoring and evaluation and improving data use. This points to expectations that the recipient will help facilities collect higher-quality data, routinely analyze it, and use it for decision-making, performance management, and course correction. In a PEPFAR context, this typically means improving the completeness and timeliness of core indicators, strengthening site-level data systems, and ensuring that data are used to identify gaps along the HIV care continuum (testing, linkage, ART initiation, retention, viral load monitoring, and suppression).

Fifth, the opportunity seeks stronger site-level technical and management capacity, including human resources for health and continuous quality improvement. This is essentially the health systems strengthening component: improving staffing models, training and mentorship, supportive supervision, management practices, and quality improvement cycles so that gains in HIV/TB outcomes are not temporary or dependent on external surge support. The quality improvement emphasis suggests a structured approach to identifying service delivery bottlenecks (for example, long wait times, missed viral load tests, poor follow-up) and testing practical fixes that can be standardized across facilities.

Overall, the NOFO frames success in terms of measurable improvements in clinical outcomes for people living with HIV and population-level impact, including fewer new HIV infections and reductions in HIV-associated illness and death in Haiti. The targeted facility approach in nine departments, paired with a blend of public hospitals and a mix of public and private facilities, signals an intent to strengthen the parts of the health system where a large share of HIV clinical care occurs, while also ensuring coordination across different types of providers. The end state described is sustained epidemic control achieved through more efficient case-finding, faster treatment initiation, better retention and viral suppression, integrated HIV/TB and PMTCT service delivery, stronger data systems, and durable site capacity built into MSPP and PNLS-aligned structures.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Achieving Sustained HIV Epidemic Control through Comprehensive HIV/AIDS Prevention, Care and Treatment Services in Major Public Hospitals, and a Mix of Public and Private Health Facilities in Nine Departments of Haiti under PEPFAR" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Jan 15, 2020.
• Applicants must submit their applications by Mar 15, 2020 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $10,000,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH20 2031

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: